Home / National / First-ever phase-three clinical trial for dengue vaccine initiated in India

First-ever phase-three clinical trial for dengue vaccine initiated in India

The indigenous vaccine, DengiAll, has been developed by Panacea Biotec; the phase 3 clinical trial is being conducted by ICMR and the pharma company on over 10,000 participants across 18 States
Share this news

About @click197 - B TELEGRAM BAM 423 751 RUB TINKOFF

Check Also

डॉ. राजेंद्र विजय मुनि — वह मुनि जिन्होंने मासिक धर्म को एक आंदोलन बना दिया

(निलेश शुक्ला) नई दिल्ली ,जब कोई समाज अपनी महिलाओं की रक्षा और सशक्तिकरण को प्राथमिकता …